WATERS CORP /DE/·4

Feb 27, 7:23 PM ET

KUEBLER CHRISTOPHER A 4

4 · WATERS CORP /DE/ · Filed Feb 27, 2026

Research Summary

AI-generated summary of this filing

Updated

Waters (WAT) Director Christopher Kuebler Receives Award

What Happened

  • Christopher A. Kuebler, a director of Waters Corporation (WAT), was granted equity awards on Feb 25, 2026. The filing reports an award of 23 shares of common stock (restricted) and a derivative grant covering 57 shares (stock option-like), both reported at $0.00 and totaling 80 shares with $0 cash exchanged. These are awards (compensation), not open-market purchases or sales.

Key Details

  • Transaction date: 2026-02-25; Form 4 filed 2026-02-27 (timely).
  • Reported prices: $0.00 for both the 23-share award and the 57-share derivative grant; total reported value $0.
  • Shares owned after transaction: Not specified in the provided filing excerpt.
  • Footnotes:
    • F1: The 23 shares are restricted and 100% of these restrictions lapse on Feb 9, 2027.
    • F2: The 57-share derivative is a stock option; the underlying shares will vest and become exercisable on Feb 9, 2027.
  • Filing status: Timely (filed within the Form 4 reporting window).

Context

  • These are standard director compensation awards—restricted shares and an option-style grant that vest in about one year—rather than a market purchase or sale. Derivative grants (options) give the holder the right to acquire shares upon vesting/exercise; this filing does not indicate any immediate sale or exercise. As with most grants, the awards reflect compensation and should not alone be taken as a buy/sell signal.

Insider Transaction Report

Form 4
Period: 2026-02-25
Transactions
  • Award

    Common Stock

    [F1]
    2026-02-25+2317,808 total
  • Award

    Stock Option (Right to Buy)

    [F2]
    2026-02-25+5757 total
    Exercise: $319.44From: 2027-02-09Exp: 2036-02-25Common Stock (57 underlying)
Footnotes (2)
  • [F1]Represents shares of common stock subject to restrictions that lapse with respect to 100% of the shares on February 9, 2027.
  • [F2]All of the shares of common stock underlying this stock option will vest and become exercisable on February 9, 2027.
Signature
/s/ Michael Lynn, attorney-in-fact for Christopher A. Kuebler|2026-02-27

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT